Analyst consensus rating
MDxHealth Analyst Rating: none
Direct answer
MDxHealth's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $1.80.
Forecast evidence checked September 7, 2026.
Get free MDxHealth email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.75
- Average price target
- $1.80
- High price target
- $3.00
- Low price target
- $1.00
- Low target gap
- +33.6%
- Target upside
- +140.5%
- High target gap
- +300.9%
- Target range width
- 267.2%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MDxHealth?
MDxHealth has a verified none consensus. The same dataset has an average price target of $1.80.
How far are MDxHealth's low and high targets from the recorded price?
The low target implies +33.6%, while the high target implies +300.9%.
How many analysts are included in MDxHealth's consensus?
The verified consensus includes 5 analysts.
How is MDxHealth's target upside or downside calculated?
The average target of $1.80 is divided by the recorded price of $0.75, then one is subtracted to produce +140.5%. This does not guarantee a future return.
When was MDxHealth's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.